Matrix metalloproteinase activation predicts amelioration of remodeling after dietary modification in injured arteries

Arterioscler Thromb Vasc Biol. 2011 Jan;31(1):102-9. doi: 10.1161/ATVBAHA.110.216036. Epub 2010 Oct 14.

Abstract

Objective: To establish and validate early noninvasive imaging of matrix metalloproteinase (MMP) activation for monitoring the progression of vascular remodeling and response to dietary modification.

Methods and results: Apolipoprotein E(-/-) mice that were fed a high-fat diet underwent left common carotid artery wire injury. One week after surgery, a group of animals were withdrawn from the high-fat diet. The other group of animals continued that diet throughout the study. Micro single-photon emission computed tomographic (microSPECT)/CT imaging with RP805 (a (99m)Tc-labeled tracer targeting activated MMPs) was repeatedly performed at 2 and 4 weeks after surgery. Histological analysis at 4 weeks showed significant left carotid neointima formation, monocyte/macrophage infiltration, and upregulation of several MMPs, which were ameliorated by withdrawal from the high-fat diet. In vivo microSPECT/CT images visualized significant RP805 uptake, reflecting MMP activation, in the injured carotid arteries. MMP activation was reduced as early as 1 week after withdrawal from the high-fat diet and significantly correlated with neointimal area at 4 weeks after surgery.

Conclusions: MMP activation predicts the progression of vascular remodeling and can track the effect of dietary modification after vascular injury.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Animals
  • Apolipoproteins E / deficiency
  • Apolipoproteins E / genetics
  • Carotid Artery Injuries / enzymology*
  • Carotid Artery Injuries / etiology
  • Carotid Artery Injuries / pathology
  • Carotid Artery, Common / drug effects
  • Carotid Artery, Common / enzymology*
  • Carotid Artery, Common / pathology
  • Dietary Fats / administration & dosage*
  • Disease Models, Animal
  • Enzyme Activation
  • Female
  • Inflammation / enzymology
  • Inflammation / etiology
  • Matrix Metalloproteinase Inhibitors
  • Matrix Metalloproteinases / metabolism*
  • Mice
  • Mice, Knockout
  • Molecular Imaging
  • Protease Inhibitors / pharmacology
  • Time Factors
  • Tomography, Emission-Computed, Single-Photon
  • X-Ray Microtomography

Substances

  • Apolipoproteins E
  • Dietary Fats
  • Matrix Metalloproteinase Inhibitors
  • Protease Inhibitors
  • Matrix Metalloproteinases